Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina

Detalhes bibliográficos
Ano de defesa: 2021
Autor(a) principal: Souza, Wesley Almeida
Orientador(a): Não Informado pela instituição
Banca de defesa: Não Informado pela instituição
Tipo de documento: Tese
Tipo de acesso: Acesso aberto
Idioma: por
Instituição de defesa: Universidade Federal de Uberlândia
Brasil
Programa de Pós-graduação em Química
Programa de Pós-Graduação: Não Informado pela instituição
Departamento: Não Informado pela instituição
País: Não Informado pela instituição
Palavras-chave em Português:
Link de acesso: https://repositorio.ufu.br/handle/123456789/31432
http://doi.org/10.14393/ufu.te.2021.45
Resumo: Metal-based drugs have been developed in order to minimize side effects and/or to overcome intrinsic or acquired resistance to antitumor drugs available in medical clinics. In this sense, we are also looking for new pharmacological agents capable of curing or at least prolonging the survival of patients with tumors classified as incurable until then. Considering the need for rational production of new antitumor agents, this work describes the synthesis and structural characterization of new complexes of Pt (II) and Pd (II) of the type [M(L1)2(L2)2] (L1 = derived from 5-alkyl-1,3,4-oxadiazole-2-thione (5-alkyl-odztH) and L2 = triphenylphosphine) and of the type [M(L1)2L2] (L1 = derived from 5-alkyl-odztH or 5-amino-1,3,4- thiadiazole-2-thiol (5amino-tdztH) and L2 = 1,10- phenanthroline). The platinum and palladium complexes were characterized by elemental analysis, conductivity measurements, high-resolution electrospray ionization mass spectrometry (HRESIMS), infrared spectroscopy (FT-IR) and multinuclear NMR spectroscopy. Three complexes of the type [Pt(L1)2(PPh3)2] and one complex of the type [Pt(L1)2fen] had their crystalline structures determined by single-crystal X-ray diffraction. In all the complexes, the metal ion was coordinated with the two L1 ligands via a sulfur atom, in which two triphenylphosphine molecules or one phenanthroline molecule completes its coordination sphere. The molar conductivity values of 1.0 × 10−3 mol L−1 solutions confirm that the complexes are non-electrolytes. The cytotoxic activity of the [Pt(heptyl-odzt)2fen] and [Pt(nonyl-odzt)2fen] complexes was evaluated in two tumor-cell lines (MCF 7 and MDA MB 231), with the complex [Pt(5 nonil odztH)2fen] being more active in both, since their IC50 values were lower. DNA interaction studies for both complexes reveled Kb values on the order of 104 M−1, with no variation observed in positive or negative bands of circular dichroism (CD) spectra. In turn, in the fluorescence spectra of the Hoechst-DNA system, an observed reduction in fluorescence intensity indicated that these complexes interact with DNA through the minor groove. These observations are in line with what is expected for compounds with lipophilic properties, as it is observed that there is a significant improvement both in cytotoxic activity and in the interaction with DNA, of the complex whose ligand has a larger aliphatic chain.
id UFU_f65e1ebd94ceb5832828a927e0e7d0c4
oai_identifier_str oai:repositorio.ufu.br:123456789/31432
network_acronym_str UFU
network_name_str Repositório Institucional da UFU
repository_id_str
spelling Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolinaObtaining Pt (II) and Pd (II) complexes derived from 1,3,4-oxadiazole-2-(3H)-thione and 5-amino-1,3,4-thiadiazole-2-thiol: antitumor potential of two Pt (II) complexes containing 1,10-phenanthrolineComplexos de platina(II)Platinum(II) complexesComplexos de paládio(II)Palladium(II) complexes5-alquil-1,3,4-oxadiazol-2-tiona5-alkyl-1,3,4-oxadiazole-2-thione5-amino-1,3,4-tiadiazol-2-tiol5-amino-1,3,4-thiadiazole-2-thiolAtividade antitumoralAntitumor activityCNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA INORGANICAPlatinaPaládioTumoresMetal-based drugs have been developed in order to minimize side effects and/or to overcome intrinsic or acquired resistance to antitumor drugs available in medical clinics. In this sense, we are also looking for new pharmacological agents capable of curing or at least prolonging the survival of patients with tumors classified as incurable until then. Considering the need for rational production of new antitumor agents, this work describes the synthesis and structural characterization of new complexes of Pt (II) and Pd (II) of the type [M(L1)2(L2)2] (L1 = derived from 5-alkyl-1,3,4-oxadiazole-2-thione (5-alkyl-odztH) and L2 = triphenylphosphine) and of the type [M(L1)2L2] (L1 = derived from 5-alkyl-odztH or 5-amino-1,3,4- thiadiazole-2-thiol (5amino-tdztH) and L2 = 1,10- phenanthroline). The platinum and palladium complexes were characterized by elemental analysis, conductivity measurements, high-resolution electrospray ionization mass spectrometry (HRESIMS), infrared spectroscopy (FT-IR) and multinuclear NMR spectroscopy. Three complexes of the type [Pt(L1)2(PPh3)2] and one complex of the type [Pt(L1)2fen] had their crystalline structures determined by single-crystal X-ray diffraction. In all the complexes, the metal ion was coordinated with the two L1 ligands via a sulfur atom, in which two triphenylphosphine molecules or one phenanthroline molecule completes its coordination sphere. The molar conductivity values of 1.0 × 10−3 mol L−1 solutions confirm that the complexes are non-electrolytes. The cytotoxic activity of the [Pt(heptyl-odzt)2fen] and [Pt(nonyl-odzt)2fen] complexes was evaluated in two tumor-cell lines (MCF 7 and MDA MB 231), with the complex [Pt(5 nonil odztH)2fen] being more active in both, since their IC50 values were lower. DNA interaction studies for both complexes reveled Kb values on the order of 104 M−1, with no variation observed in positive or negative bands of circular dichroism (CD) spectra. In turn, in the fluorescence spectra of the Hoechst-DNA system, an observed reduction in fluorescence intensity indicated that these complexes interact with DNA through the minor groove. These observations are in line with what is expected for compounds with lipophilic properties, as it is observed that there is a significant improvement both in cytotoxic activity and in the interaction with DNA, of the complex whose ligand has a larger aliphatic chain.CAPES - Coordenação de Aperfeiçoamento de Pessoal de Nível SuperiorFAPEMIG - Fundação de Amparo a Pesquisa do Estado de Minas GeraisTese (Doutorado)Metalofármacos vêm sendo desenvolvidos com o intuito de minimizar os efeitos colaterais e/ou sobrepujar a resistência intrínseca ou adquirida aos medicamentos antitumorais disponíveis na clínica médica. Neste sentido, buscam-se também novos agentes farmacológicos capazes de curar ou de pelo menos aumentar a sobrevida de pacientes com tumores classificados como incuráveis até então. Considerando a necessidade de produção racional de novos agentes antitumorais, este trabalho descreve a síntese e caracterização estrutural de novos complexos de Pt(II) e Pd(II) do tipo [M(L1)2(L2)2] (L1 = derivados de 5-alquil-1,3,4-oxadiazol-2-tiona (5-alquil-odztH) e L2 = trifenilfosfina) e do tipo [M(L1)2L2] (L1 = derivados de 5-alquil-odztH ou 5-amino-1,3,4-tiadiazol-2-tiol (5amino-tdztH) e L2 = 1,10-fenantrolina). Os complexos de platina e paládio foram caracterizados por análise elementar, medidas de condutividade, espectrometria de massas em alta resolução com ionização por electrospray (HRESIMS), espectroscopia de infravermelho (FT-IR) e RMN multinuclear. Três complexos do tipo [Pt(L1)2(PPh3)2] e um complexo do tipo [Pt(L1)2fen] tiveram suas estruturas cristalinas determinadas por difração de raios-X por monocristais. Em todos os complexos, o íon metálico coordenou-se aos dois ligantes L1 via átomo de enxofre, no qual duas moléculas de trifenilfosfina ou uma de fenantrolina completam sua esfera de coordenação. Os valores de condutividade molar de soluções 1,0 × 10−3 mol L−1 confirmam que os complexos são não eletrólitos. A atividade citotóxica dos complexos [Pt(heptil-odzt)2fen] e [Pt(nonil-odzt)2fen] foi avaliada em duas linhagens de células tumorais (MCF 7 e MDA-MB-231), sendo o complexo [Pt(5 nonil odzt)2fen] mais ativo em ambas, uma vez que os seus valores de IC50 foram menores. Estudos de interação com o ADN para ambos os complexos revelaram valores de Kb na ordem de 104 M−1, não sendo observado nenhuma variação nas bandas positivas e negativas nos espectros de dicroísmo circular (DC). Por sua vez, nos espectros de fluorescência do sistema Hoechst ADN observou-se uma redução na intensidade de fluorescência, indicando que estes complexos interagem com o ADN por meio do sulco menor. Estas observações estão de acordo com o esperado para os compostos com propriedades lipofílicas, pois é observado que há uma melhora significativa tanto na atividade citotóxica quanto na interação com o ADN, do complexo cujo ligante apresenta uma cadeia alifática maior.Universidade Federal de UberlândiaBrasilPrograma de Pós-graduação em QuímicaResende, Jackson Antonio Lamounier Camargoshttp://lattes.cnpq.br/2938388317505882Guerra, Wendellhttp://lattes.cnpq.br/8904957949852036Poelhsitz, Gustavo Vonhttp://lattes.cnpq.br/8535446070593443Maia, Elene Cristina Pereirahttp://lattes.cnpq.br/7615891473051775Cuin, Alexandrehttp://lattes.cnpq.br/6517745478286590Oliveira, Carolina Gonçalveshttp://lattes.cnpq.br/7092893236728387Souza, Wesley Almeida2021-03-15T13:21:47Z2021-03-15T13:21:47Z2021-02-24info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesisapplication/pdfSOUZA, Wesley Almeida. Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina. 2021. 180 f. Tese (Doutorado em Química) - Universidade Federal de Uberlândia, Uberlândia. 2021. DOI http://doi.org/10.14393/ufu.te.2021.45.https://repositorio.ufu.br/handle/123456789/31432http://doi.org/10.14393/ufu.te.2021.45porhttp://creativecommons.org/licenses/by-nc-nd/3.0/us/info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFUinstname:Universidade Federal de Uberlândia (UFU)instacron:UFU2021-03-16T06:16:44Zoai:repositorio.ufu.br:123456789/31432Repositório InstitucionalONGhttp://repositorio.ufu.br/oai/requestdiinf@dirbi.ufu.bropendoar:2021-03-16T06:16:44Repositório Institucional da UFU - Universidade Federal de Uberlândia (UFU)false
dc.title.none.fl_str_mv Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina
Obtaining Pt (II) and Pd (II) complexes derived from 1,3,4-oxadiazole-2-(3H)-thione and 5-amino-1,3,4-thiadiazole-2-thiol: antitumor potential of two Pt (II) complexes containing 1,10-phenanthroline
title Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina
spellingShingle Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina
Souza, Wesley Almeida
Complexos de platina(II)
Platinum(II) complexes
Complexos de paládio(II)
Palladium(II) complexes
5-alquil-1,3,4-oxadiazol-2-tiona
5-alkyl-1,3,4-oxadiazole-2-thione
5-amino-1,3,4-tiadiazol-2-tiol
5-amino-1,3,4-thiadiazole-2-thiol
Atividade antitumoral
Antitumor activity
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA INORGANICA
Platina
Paládio
Tumores
title_short Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina
title_full Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina
title_fullStr Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina
title_full_unstemmed Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina
title_sort Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina
author Souza, Wesley Almeida
author_facet Souza, Wesley Almeida
author_role author
dc.contributor.none.fl_str_mv Resende, Jackson Antonio Lamounier Camargos
http://lattes.cnpq.br/2938388317505882
Guerra, Wendell
http://lattes.cnpq.br/8904957949852036
Poelhsitz, Gustavo Von
http://lattes.cnpq.br/8535446070593443
Maia, Elene Cristina Pereira
http://lattes.cnpq.br/7615891473051775
Cuin, Alexandre
http://lattes.cnpq.br/6517745478286590
Oliveira, Carolina Gonçalves
http://lattes.cnpq.br/7092893236728387
dc.contributor.author.fl_str_mv Souza, Wesley Almeida
dc.subject.por.fl_str_mv Complexos de platina(II)
Platinum(II) complexes
Complexos de paládio(II)
Palladium(II) complexes
5-alquil-1,3,4-oxadiazol-2-tiona
5-alkyl-1,3,4-oxadiazole-2-thione
5-amino-1,3,4-tiadiazol-2-tiol
5-amino-1,3,4-thiadiazole-2-thiol
Atividade antitumoral
Antitumor activity
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA INORGANICA
Platina
Paládio
Tumores
topic Complexos de platina(II)
Platinum(II) complexes
Complexos de paládio(II)
Palladium(II) complexes
5-alquil-1,3,4-oxadiazol-2-tiona
5-alkyl-1,3,4-oxadiazole-2-thione
5-amino-1,3,4-tiadiazol-2-tiol
5-amino-1,3,4-thiadiazole-2-thiol
Atividade antitumoral
Antitumor activity
CNPQ::CIENCIAS EXATAS E DA TERRA::QUIMICA::QUIMICA INORGANICA
Platina
Paládio
Tumores
description Metal-based drugs have been developed in order to minimize side effects and/or to overcome intrinsic or acquired resistance to antitumor drugs available in medical clinics. In this sense, we are also looking for new pharmacological agents capable of curing or at least prolonging the survival of patients with tumors classified as incurable until then. Considering the need for rational production of new antitumor agents, this work describes the synthesis and structural characterization of new complexes of Pt (II) and Pd (II) of the type [M(L1)2(L2)2] (L1 = derived from 5-alkyl-1,3,4-oxadiazole-2-thione (5-alkyl-odztH) and L2 = triphenylphosphine) and of the type [M(L1)2L2] (L1 = derived from 5-alkyl-odztH or 5-amino-1,3,4- thiadiazole-2-thiol (5amino-tdztH) and L2 = 1,10- phenanthroline). The platinum and palladium complexes were characterized by elemental analysis, conductivity measurements, high-resolution electrospray ionization mass spectrometry (HRESIMS), infrared spectroscopy (FT-IR) and multinuclear NMR spectroscopy. Three complexes of the type [Pt(L1)2(PPh3)2] and one complex of the type [Pt(L1)2fen] had their crystalline structures determined by single-crystal X-ray diffraction. In all the complexes, the metal ion was coordinated with the two L1 ligands via a sulfur atom, in which two triphenylphosphine molecules or one phenanthroline molecule completes its coordination sphere. The molar conductivity values of 1.0 × 10−3 mol L−1 solutions confirm that the complexes are non-electrolytes. The cytotoxic activity of the [Pt(heptyl-odzt)2fen] and [Pt(nonyl-odzt)2fen] complexes was evaluated in two tumor-cell lines (MCF 7 and MDA MB 231), with the complex [Pt(5 nonil odztH)2fen] being more active in both, since their IC50 values were lower. DNA interaction studies for both complexes reveled Kb values on the order of 104 M−1, with no variation observed in positive or negative bands of circular dichroism (CD) spectra. In turn, in the fluorescence spectra of the Hoechst-DNA system, an observed reduction in fluorescence intensity indicated that these complexes interact with DNA through the minor groove. These observations are in line with what is expected for compounds with lipophilic properties, as it is observed that there is a significant improvement both in cytotoxic activity and in the interaction with DNA, of the complex whose ligand has a larger aliphatic chain.
publishDate 2021
dc.date.none.fl_str_mv 2021-03-15T13:21:47Z
2021-03-15T13:21:47Z
2021-02-24
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv SOUZA, Wesley Almeida. Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina. 2021. 180 f. Tese (Doutorado em Química) - Universidade Federal de Uberlândia, Uberlândia. 2021. DOI http://doi.org/10.14393/ufu.te.2021.45.
https://repositorio.ufu.br/handle/123456789/31432
http://doi.org/10.14393/ufu.te.2021.45
identifier_str_mv SOUZA, Wesley Almeida. Obtenção de complexos de Pt(II) e Pd(II) derivados de 1,3,4-oxadiazol-2-(3H)-tiona e 5-amino-1,3,4-tiadiazol-2-tiol: potencial antitumoral de dois complexos de Pt(II) contendo 1,10-fenantrolina. 2021. 180 f. Tese (Doutorado em Química) - Universidade Federal de Uberlândia, Uberlândia. 2021. DOI http://doi.org/10.14393/ufu.te.2021.45.
url https://repositorio.ufu.br/handle/123456789/31432
http://doi.org/10.14393/ufu.te.2021.45
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/3.0/us/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/3.0/us/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Uberlândia
Brasil
Programa de Pós-graduação em Química
publisher.none.fl_str_mv Universidade Federal de Uberlândia
Brasil
Programa de Pós-graduação em Química
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFU
instname:Universidade Federal de Uberlândia (UFU)
instacron:UFU
instname_str Universidade Federal de Uberlândia (UFU)
instacron_str UFU
institution UFU
reponame_str Repositório Institucional da UFU
collection Repositório Institucional da UFU
repository.name.fl_str_mv Repositório Institucional da UFU - Universidade Federal de Uberlândia (UFU)
repository.mail.fl_str_mv diinf@dirbi.ufu.br
_version_ 1827843435223056384